Regenxbio Inc (RGNX)
8.77
-0.02
(-0.23%)
USD |
NASDAQ |
Nov 04, 16:00
8.765
0.00 (0.00%)
After-Hours: 20:00
Regenxbio Market Cap: 433.44M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 434.43M |
| October 31, 2024 | 424.55M |
| October 30, 2024 | 436.90M |
| October 29, 2024 | 447.77M |
| October 28, 2024 | 463.59M |
| October 25, 2024 | 462.11M |
| October 24, 2024 | 473.47M |
| October 23, 2024 | 481.38M |
| October 22, 2024 | 473.97M |
| October 21, 2024 | 512.52M |
| October 18, 2024 | 548.60M |
| October 17, 2024 | 523.89M |
| October 16, 2024 | 531.30M |
| October 15, 2024 | 509.06M |
| October 14, 2024 | 504.12M |
| October 11, 2024 | 488.80M |
| October 10, 2024 | 459.14M |
| October 09, 2024 | 456.67M |
| October 08, 2024 | 472.49M |
| October 07, 2024 | 470.51M |
| October 04, 2024 | 480.39M |
| October 03, 2024 | 462.11M |
| October 02, 2024 | 490.28M |
| October 01, 2024 | 504.61M |
| September 30, 2024 | 518.45M |
| Date | Value |
|---|---|
| September 27, 2024 | 533.77M |
| September 26, 2024 | 527.84M |
| September 25, 2024 | 535.25M |
| September 24, 2024 | 554.03M |
| September 23, 2024 | 576.77M |
| September 20, 2024 | 577.76M |
| September 19, 2024 | 617.79M |
| September 18, 2024 | 619.27M |
| September 17, 2024 | 640.03M |
| September 16, 2024 | 629.65M |
| September 13, 2024 | 634.59M |
| September 12, 2024 | 601.97M |
| September 11, 2024 | 628.17M |
| September 10, 2024 | 582.70M |
| September 09, 2024 | 563.42M |
| September 06, 2024 | 567.38M |
| September 05, 2024 | 562.44M |
| September 04, 2024 | 557.49M |
| September 03, 2024 | 560.46M |
| August 30, 2024 | 603.95M |
| August 29, 2024 | 593.08M |
| August 28, 2024 | 581.22M |
| August 27, 2024 | 573.80M |
| August 26, 2024 | 598.52M |
| August 23, 2024 | 599.50M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
424.55M
Minimum
Oct 31 2024
2.117B
Maximum
Jan 14 2021
1.146B
Average
1.101B
Median
Market Cap Benchmarks
| Sarepta Therapeutics Inc | 11.74B |
| Catalyst Pharmaceuticals Inc | 2.581B |
| Vertex Pharmaceuticals Inc | 122.14B |
| Edgewise Therapeutics Inc | 3.235B |
| Entrada Therapeutics Inc | 660.11M |
Market Cap Related Metrics
| PS Ratio | 4.538 |
| Price to Book Value | 1.245 |
| Price | 8.77 |
| Earnings Yield | -59.98% |